Coding Ahead
CasePilot
Medical Coding Assistant
Case2Code
Search and Code Lookup Tool
RedactPHI
HIPAA-Compliant PHI Redaction
DetectICD10CM
ICD-10-CM Code Detection
Log in Register free account
1 code page views remaining. Guest accounts are limited to 1 page view. Register free account to get 5 more views.
Log in Register free account

Official Description

Injection into turbinate(s), therapeutic

© Copyright 2025 American Medical Association. All rights reserved.

Common Language Description

A therapeutic injection into the turbinate(s) involves administering medication directly into one or more of the nasal turbinate bones, which are essential structures within the nasal cavity. The turbinate bones, also known as nasal conchae, consist of three pairs located on each side of the nose: the inferior, middle, and superior turbinates. These thin, spongy bony plates play a crucial role in regulating airflow and humidifying the air we breathe. The inferior turbinate is positioned to separate the middle meatus from the inferior meatus, while the middle turbinate divides the superior meatus from the middle meatus. The superior turbinate, on the other hand, separates the superior meatus from the sphenoethmoid recess. The primary purpose of this injection is to deliver corticosteroids into the mucosa of the turbinate bones, which is particularly beneficial for patients suffering from allergic or vasomotor rhinitis. By injecting the medication, a bleb is formed over the turbinate bone, facilitating a slow and sustained release of the corticosteroid into the surrounding tissue. This method aims to alleviate symptoms associated with nasal congestion and inflammation, providing therapeutic relief to patients experiencing these conditions.

© Copyright 2025 Coding Ahead. All rights reserved.

1. Indications

The therapeutic injection into the turbinate(s) is indicated for the treatment of specific nasal conditions. The following are the primary indications for this procedure:

  • Allergic Rhinitis - A condition characterized by an allergic reaction that causes inflammation and swelling of the nasal mucosa, leading to symptoms such as sneezing, itching, and nasal congestion.
  • Vasomotor Rhinitis - A non-allergic condition that results in nasal congestion and other symptoms due to abnormal regulation of blood flow in the nasal mucosa, often triggered by environmental factors such as changes in temperature or humidity.

2. Procedure

The procedure for administering a therapeutic injection into the turbinate(s) involves several key steps to ensure accuracy and effectiveness. Each step is crucial for achieving the desired therapeutic outcome.

  • Step 1: Patient Preparation - The patient is positioned comfortably, and the healthcare provider explains the procedure to ensure understanding and consent. The nasal cavity may be examined to assess the condition of the turbinates and identify the appropriate site for injection.
  • Step 2: Anesthesia Application - Local anesthesia may be applied to the nasal mucosa to minimize discomfort during the injection. This can involve the use of topical anesthetic sprays or gels to numb the area effectively.
  • Step 3: Injection Technique - Using a syringe, the healthcare provider carefully injects the corticosteroid into the selected turbinate(s). The injection is typically performed at a specific angle to ensure that the medication is delivered into the mucosa, forming a bleb that allows for gradual absorption into the surrounding tissue.
  • Step 4: Post-Injection Observation - After the injection, the patient is monitored for a short period to observe for any immediate adverse reactions or complications. This ensures that the patient is stable before they leave the healthcare setting.

3. Post-Procedure

Following the therapeutic injection into the turbinate(s), patients may experience some mild discomfort or swelling at the injection site, which is typically temporary. It is important for patients to follow any post-procedure instructions provided by their healthcare provider, which may include avoiding strenuous activities or exposure to irritants for a specified period. Patients should also be advised to monitor their symptoms and report any unusual reactions, such as excessive bleeding or signs of infection, to their healthcare provider. The expected recovery time is generally short, with many patients experiencing relief from their symptoms within a few days as the medication takes effect.

Short Descr INJECTION TREATMENT OF NOSE
Medium Descr INJECTION TURBINATE THERAPEUTIC
Long Descr Injection into turbinate(s), therapeutic
Status Code Active Code
Global Days 000 - Endoscopic or Minor Procedure
PC/TC Indicator (26, TC) 0 - Physician Service Code
Multiple Procedures (51) 2 - Standard payment adjustment rules for multiple procedures apply.
Bilateral Surgery (50) 0 - 150% payment adjustment for bilateral procedures does NOT apply.
Physician Supervisions 09 - Concept does not apply.
Assistant Surgeon (80, 82) 1 - Statutory payment restriction for assistants at surgery applies to this procedure...
Co-Surgeons (62) 0 - Co-surgeons not permitted for this procedure.
Team Surgery (66) 0 - Team surgeons not permitted for this procedure.
Diagnostic Imaging Family 99 - Concept Does Not Apply
APC Status Indicator Procedure or Service, Multiple Reduction Applies
ASC Payment Indicator Office-based surgical procedure added to ASC list in CY 2008 or later with MPFS nonfacility PE RVUs; payment based on MPFS nonfacility PE RVUs.
Type of Service (TOS) 2 - Surgery
Berenson-Eggers TOS (BETOS) P6C - Minor procedures - other (Medicare fee schedule)
MUE 1
CCS Clinical Classification 32 - Other non-OR therapeutic procedures on nose, mouth and pharynx
51 Multiple procedures: when multiple procedures, other than e/m services, physical medicine and rehabilitation services or provision of supplies (eg, vaccines), are performed at the same session by the same individual, the primary procedure or service may be reported as listed. the additional procedure(s) or service(s) may be identified by appending modifier 51 to the additional procedure or service code(s). note: this modifier should not be appended to designated "add-on" codes (see appendix d).
59 Distinct procedural service: under certain circumstances, it may be necessary to indicate that a procedure or service was distinct or independent from other non-e/m services performed on the same day. modifier 59 is used to identify procedures/services, other than e/m services, that are not normally reported together, but are appropriate under the circumstances. documentation must support a different session, different procedure or surgery, different site or organ system, separate incision/excision, separate lesion, or separate injury (or area of injury in extensive injuries) not ordinarily encountered or performed on the same day by the same individual. however, when another already established modifier is appropriate it should be used rather than modifier 59. only if no more descriptive modifier is available, and the use of modifier 59 best explains the circumstances, should modifier 59 be used. note: modifier 59 should not be appended to an e/m service. to report a separate and distinct e/m service with a non-e/m service performed on the same date, see modifier 25.
58 Staged or related procedure or service by the same physician or other qualified health care professional during the postoperative period: it may be necessary to indicate that the performance of a procedure or service during the postoperative period was: (a) planned or anticipated (staged); (b) more extensive than the original procedure; or (c) for therapy following a surgical procedure. this circumstance may be reported by adding modifier 58 to the staged or related procedure. note: for treatment of a problem that requires a return to the operating/procedure room (eg, unanticipated clinical condition), see modifier 78.
78 Unplanned return to the operating/procedure room by the same physician or other qualified health care professional following initial procedure for a related procedure during the postoperative period: it may be necessary to indicate that another procedure was performed during the postoperative period of the initial procedure (unplanned procedure following initial procedure). when this procedure is related to the first, and requires the use of an operating/procedure room, it may be reported by adding modifier 78 to the related procedure. (for repeat procedures, see modifier 76.)
79 Unrelated procedure or service by the same physician or other qualified health care professional during the postoperative period: the individual may need to indicate that the performance of a procedure or service during the postoperative period was unrelated to the original procedure. this circumstance may be reported by using modifier 79. (for repeat procedures on the same day, see modifier 76.)
AQ Physician providing a service in an unlisted health professional shortage area (hpsa)
GC This service has been performed in part by a resident under the direction of a teaching physician
GV Attending physician not employed or paid under arrangement by the patient's hospice provider
LT Left side (used to identify procedures performed on the left side of the body)
RT Right side (used to identify procedures performed on the right side of the body)
XS Separate structure, a service that is distinct because it was performed on a separate organ/structure
XU Unusual non-overlapping service, the use of a service that is distinct because it does not overlap usual components of the main service
Date
Action
Notes
Pre-1990 Added Code added.
Code
Description
Code
Description
Code
Description
Code
Description
Code
Description
CasePilot

Get instant expert-level medical coding assistance.

Ask about:
CPT Codes Guidelines Modifiers Crosswalks NCCI Edits Compliance Medicare Coverage
Example: "What is CPT code 99213?" or "Guidelines for E/M services"